TRCT
MAIA icon

Tower Research Capital (TRC)’s MAIA Biotechnology MAIA Stock Holding History

Tower Research Capital (TRC)’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,026
Closed -$6.2K – 5417
2025
Q3 		$6.2K Buy
4,026
+2,179
+118% +$3.56K ﹤0.01% 4174
2025
Q2 		$3.33K Buy
1,847
+1,608
+673% +$2.88K ﹤0.01% 4520
2025
Q1 		$366 Sell
239
-3,046
-93% -$5.64K ﹤0.01% 4920
2024
Q4 		$6.5K Buy
3,285
+1,819
+124% +$4.36K ﹤0.01% 4164
2024
Q3 		$4.12K Sell
1,466
-3,273
-69% -$10.2K ﹤0.01% 4667
2024
Q2 		$16.2K Sell
4,739
-926
-16% -$2.92K ﹤0.01% 3876
2024
Q1 		$12.5K Buy
5,665
+2,071
+58% +$3.11K ﹤0.01% 3479
2023
Q4 		$4.21K Sell
3,594
-1,329
-27% -$2.15K ﹤0.01% 4982
2023
Q3 		$10.8K Buy
4,923
+961
+24% +$1.9K ﹤0.01% 4072
2023
Q2 		$8.72K Buy
3,962
+1,256
+46% +$3.36K ﹤0.01% 4381
2023
Q1 		$9K Buy
+2,706
New +$11.1K ﹤0.01% 4511
2022
Q4 		– Sell
-311
Closed -$1K – 6182
2022
Q3 		$1K Buy
+311
New +$1.32K ﹤0.01% 5805

Other funds holding MAIA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $5.76B AUM 24.57% 1-Year Est. Return

Tower Research Capital (TRC)'s MAIA Position: Q4 2025 in Review

Tower Research Capital (TRC) sold out of MAIA Biotechnology (MAIA) in Q4 2025, closing a stake of 4,026 shares — an estimated $6.2K sold.

Tower Research Capital (TRC) first reported a position in MAIA in Q3 2022 and held it in 12 quarters. The position peaked at $16.2K in Q2 2024. 26 funds tracked by Wall St. Rank hold MAIA as of Q4 2025.

  • Tower Research Capital (TRC) reported no remaining MAIA Biotechnology position as of Q4 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 4,026 MAIA Biotechnology shares in Q4 2025, an estimated $6.2K.
  • Tower Research Capital (TRC) first reported a position in MAIA Biotechnology in Q3 2022 and held it in 12 quarters.
  • Tower Research Capital (TRC)'s MAIA Biotechnology position peaked at $16.2K in Q2 2024.
  • 26 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q4 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2025, filed 17 Feb 2026.